MP 153 Pill — WHITE ROUND, 8mm — Atenolol

Imprint	MP / 153
Colour	WHITE
Shape	ROUND
Size	8
Strength	Atenolol 50 mg;Chlorthalidone 25 mg
Dosage form	Tablet
Manufacturer	Major Pharmaceutical
NDC	0904-6200
Schedule	—
Availability	—
Ingredients	Atenolol[Atenolol];Chlorthalidone[Chlorthalidone]

What does this imprint mean?

The imprint "MP 153" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Atenolol

Uses and warnings

No boxed warning. Contraindications: "sinus bradycardia, heart block greater than first degree, cardiogenic shock, and overt cardiac failure," and known hypersensitivity. Key warnings: beta-blockers can precipitate cardiac failure because "sympathetic stimulation is necessary in supporting circulatory function"; abrupt cessation has caused "severe exacerbation of angina and occurrence of myocardial infarction and ventricular arrhythmias"; "PATIENTS WITH BRONCHOSPASTIC DISEASE SHOULD, IN GENERAL, NOT RECEIVE BETA-BLOCKERS"; may mask hypoglycemia warning signs such as tachycardia; and "atenolol can cause fetal harm when administered to a pregnant woman."

Atenolol tablets are indicated for: - Treatment of hypertension, "to lower blood pressure" and reduce the risk of fatal and nonfatal cardiovascular events such as strokes and myocardial infarctions - Long-term management of patients with angina pectoris - Management of hemodynamically stable patients with definite or suspected acute myocardial infarction, "to reduce cardiovascular mortality."

Read the full drug profile →